Merel E. Hellemons

7.0k total citations
53 papers, 1.1k citations indexed

About

Merel E. Hellemons is a scholar working on Surgery, Neurology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Merel E. Hellemons has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Neurology and 13 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Merel E. Hellemons's work include Transplantation: Methods and Outcomes (16 papers), Long-Term Effects of COVID-19 (15 papers) and Intensive Care Unit Cognitive Disorders (12 papers). Merel E. Hellemons is often cited by papers focused on Transplantation: Methods and Outcomes (16 papers), Long-Term Effects of COVID-19 (15 papers) and Intensive Care Unit Cognitive Disorders (12 papers). Merel E. Hellemons collaborates with scholars based in Netherlands, Denmark and Germany. Merel E. Hellemons's co-authors include Stephan J. L. Bakker, Dick de Zeeuw, Hiddo J.L. Heerspink, Rogier A.S. Hoek, Peter Rossing, Ron T. Gansevoort, Maria Lajer, Sara S. Roscioni, Olivier C. Manintveld and Frederik Persson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

Merel E. Hellemons

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merel E. Hellemons Netherlands	19	227	213	180	155	149	53	1.1k
Felix S. Seibert Germany	20	289 1.3×	212 1.0×	99 0.6×	147 0.9×	144 1.0×	78	1.3k
Martin I. Sigurðsson Iceland	22	205 0.9×	327 1.5×	209 1.2×	116 0.7×	369 2.5×	128	1.9k
Jae Won Yang South Korea	16	184 0.8×	138 0.6×	138 0.8×	288 1.9×	217 1.5×	75	1.2k
Tiziana Ciarambino Italy	19	117 0.5×	87 0.4×	127 0.7×	155 1.0×	147 1.0×	65	945
Jian Ying United States	16	254 1.1×	381 1.8×	150 0.8×	46 0.3×	157 1.1×	51	1.3k
Stefano Federico Italy	22	237 1.0×	212 1.0×	280 1.6×	82 0.5×	206 1.4×	66	1.4k
Murat Hayri Sipahioğlu Türkiye	21	606 2.7×	250 1.2×	120 0.7×	60 0.4×	175 1.2×	127	1.5k
Oktay Oymak Türkiye	21	556 2.4×	237 1.1×	226 1.3×	84 0.5×	179 1.2×	150	1.5k
Mariano Andrés Spain	20	638 2.8×	322 1.5×	100 0.6×	330 2.1×	206 1.4×	100	1.5k
Alexy Tran‐Dinh France	19	41 0.2×	361 1.7×	336 1.9×	224 1.4×	174 1.2×	87	1.2k

Countries citing papers authored by Merel E. Hellemons

Since Specialization

Citations

This map shows the geographic impact of Merel E. Hellemons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merel E. Hellemons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merel E. Hellemons more than expected).

Fields of papers citing papers by Merel E. Hellemons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merel E. Hellemons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merel E. Hellemons. The network helps show where Merel E. Hellemons may publish in the future.

Co-authorship network of co-authors of Merel E. Hellemons

This figure shows the co-authorship network connecting the top 25 collaborators of Merel E. Hellemons. A scholar is included among the top collaborators of Merel E. Hellemons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merel E. Hellemons. Merel E. Hellemons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hellemons, Merel E., Eva Van Braeckel, C. Tji Gan, et al.. (2025). Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study. JHLT Open. 7. 100210–100210.

Gottlieb, Jens, Erika D. Lease, Merel E. Hellemons, K. Halloran, & Tereza Martinu. (2025). Worldwide practices in pulmonary function test reporting after lung transplantation. JHLT Open. 9. 100347–100347.

Duiverman, Marieke L., Martijn D. de Kruif, Daniela E. Oprea‐Lager, et al.. (2025). [68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge. European Journal of Nuclear Medicine and Molecular Imaging. 53(1). 565–573. 1 indexed citations

Mahtab, Edris A.F., et al.. (2024). Effect of rotational thromboelastometry-guided bleeding management in bilateral lung transplantation. SHILAP Revista de lepidopterología. 3. 100055–100055.

Hellemons, Merel E., Kathryn Hoffmann, Joanne VanDerNagel, et al.. (2024). Graded exercise therapy should not be recommended for patients with post-exertional malaise. Nature Reviews Cardiology. 21(6). 430–431. 6 indexed citations

Sijs, Heleen van der, et al.. (2024). Recurrent treatment of refractory acute cellular rejection with alemtuzumab after lung transplantation. The Journal of Heart and Lung Transplantation. 43(11). 1864–1868.

Luijk, Bart, Merel E. Hellemons, Renske van der Meer, et al.. (2024). The Multicenter KOALA Study: The Effects of Kaftrio After Lung Transplantation in Cystic Fibrosis. The Journal of Heart and Lung Transplantation. 43(4). S36–S36. 1 indexed citations

Miedema, Jelle, Jan H. von der Thüsen, Henrik Endeman, et al.. (2023). Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients. Frontiers in Immunology. 14. 2 indexed citations

Hellemons, Merel E., Susanne M. Huijts, Jasper van Bommel, et al.. (2023). Cognitive and psychological recovery patterns across different care pathways 12 months after hospitalization for COVID-19: A multicenter cohort study (CO-FLOW). Annals of Physical and Rehabilitation Medicine. 66(5). 101737–101737. 5 indexed citations

10.

Magouliotis, Dimitrios E., Saskia Bos, Marco Nardini, et al.. (2023). ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly. ERJ Open Research. 9(2). 671–2022.

11.

Hoek, Rogier A.S., Leonard Seghers, Catharina C. Moor, et al.. (2022). Diagnostic performance of electronic nose technology in chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 42(2). 236–245. 6 indexed citations

12.

Malahe, S. Reshwan K., Rogier A.S. Hoek, Virgil A. S. H. Dalm, et al.. (2022). Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study. Clinical Infectious Diseases. 76(3). e172–e178. 56 indexed citations

13.

Heijenbrok‐Kal, Majanka H., Susanne M. Huijts, Michel E. van Genderen, et al.. (2022). Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study. ERJ Open Research. 8(4). 355–2022. 15 indexed citations

14.

Hoek, Rogier A.S., Erik A.M. Verschuuren, Rory D. de Vries, et al.. (2022). High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients. The Journal of Heart and Lung Transplantation. 41(6). 765–772. 20 indexed citations

15.

Vlake, Johan H., Jasper van Bommel, Evert‐Jan Wils, et al.. (2022). Intensive Care Unit–Specific Virtual Reality for Critically Ill Patients With COVID-19: Multicenter Randomized Controlled Trial. Journal of Medical Internet Research. 24(1). e32368–e32368. 46 indexed citations

16.

Hellemons, Merel E., et al.. (2022). The clinical validation of a dried blood spot method for simultaneous measurement of cyclosporine A, tacrolimus, creatinine, and hematocrit. Clinica Chimica Acta. 535. 131–139. 14 indexed citations

17.

Roscioni, Sara S., Dick de Zeeuw, Merel E. Hellemons, et al.. (2012). A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia. 56(2). 259–267. 123 indexed citations

18.

Hellemons, Merel E., Petra Denig, Dick de Zeeuw, Jaco Voorham, & Hiddo J.L. Heerspink. (2012). Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort. Nephrology Dialysis Transplantation. 28(3). 706–715. 13 indexed citations

19.

Hellemons, Merel E., Julia Kerschbaum, Stephan J. L. Bakker, et al.. (2011). Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Diabetic Medicine. 29(5). 567–577. 61 indexed citations

20.

Hellemons, Merel E., Stephan J. L. Bakker, Douwe Postmus, et al.. (2011). Incidence of impaired renal function after lung transplantation. The Journal of Heart and Lung Transplantation. 31(3). 238–243. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact